HealthEquity stock holds near 52-week high after strong first-quarter results

Published on 09/20/2026 at 19:45 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

HealthEquity stock trades close to its 52-week high after the company reported solid first-quarter fiscal 2027 growth in June 2026. Revenue and adjusted earnings rose against the prior year as the HSA specialist expanded its member base.

HQY, US42226C1071, Illustration mit AI erstellt.

HealthEquity stock (ISIN US42226C1071) is trading near its recent 52-week high after the Health Savings Account specialist delivered robust growth in its latest reported quarter for fiscal 2027, giving investors fresh numbers to assess as of September 20, 2026.

First-quarter fiscal 2027 results drive the narrative

HealthEquity, Inc. reported results for the first quarter of its fiscal 2027 year, which ended on April 30, 2026, showing a clear increase in both revenue and earnings compared with the prior-year period, according to HealthEquity in its June 2026 earnings release.

In that fiscal 2027 first quarter, HealthEquity generated revenue meaningfully above the prior-year quarter, and adjusted earnings per share improved versus fiscal 2026, as the company continued to grow the number of Health Savings Accounts and related assets under administration, based on figures presented by HealthEquity for that period.

Stock valuation and recent trading range

In current market trading around September 20, 2026, HealthEquity stock is quoted at about USD 95 on Nasdaq, only a few percent below a 52-week high near the upper 90-dollar range and clearly above the lower 70-dollar area that marked its 52-week low earlier in the period, with a market capitalization close to USD 7.9 billion as of mid-September 2026.

The narrow gap between the recent share price of roughly USD 95 and the 52-week high just under USD 100 underscores how investors have rewarded the company’s execution since fiscal 2026, with the current market capitalization of about USD 7.9 billion as of September 18, 2026 reflecting expectations for continued HSA-driven growth.

Operational momentum and investor perspective

For investors, the central point is that HealthEquity’s latest fiscal 2027 first-quarter figures from April 30, 2026 confirmed that revenue and earnings are still rising year on year, supported by steady increases in Health Savings Accounts, associated balances, and employer relationships, as laid out in the company’s June 2026 earnings materials from HealthEquity.

Against that backdrop, HealthEquity stock hovering near its 52-week high level in mid-September 2026 encapsulates the market’s current stance: pricing in the strong recent growth while watching how management will sustain that trajectory through the rest of fiscal 2027.

Stock price level and as-of date

As of September 18, 2026, the most recent completed trading day, HealthEquity stock closed on Nasdaq at approximately USD 95, leaving the shares only a small distance below their 52-week high in the high 90-dollar range and well above the 52-week low in the low 70-dollar band.